Purchase Order 75N95025P00311
Award Date
7/2/25
Potential Completion Date
8/1/25
Potential Value
$17K
Federal Agency
National Institute on Drug Abuse
Awardee
Novandi Chemistry AB
Ultimate Awardee
Not listed
NAICS Category
325199 - All Other Basic Organic Chemical Manufacturing
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $15,650.00 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Novandi Chemistry AB, a for-profit manufacturer of goods. The contract is for the supply of tritiated cocaine to support binding experiments investigating how novel receptors interact with drugs in vivo. Novandi Chemistry AB is a vendor that specializes in providing radioactive materials and custom synthesis services for drug...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
The National Institutes of Health's National Institute on Drug Abuse awarded a $14,900 firm fixed price purchase order to Novandi Chemistry AB of Baltimore, Maryland. The contract calls for the delivery of tritiated heroin to support binding experiments investigating how heroin and its metabolites bind in vivo. As the lead federal agency supporting scientific research on drug abuse and addiction, the National Institute on Drug Abuse uses contracts such as this to further its mission of advancing...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse to Novandi Chemistry AB, a manufacturer of goods. The $10,400.00 contract is for the delivery of radioactive materials, including tritium, carbon 14, and stable labeling chemistry services, to support research related to drugs of abuse. Novandi Chemistry AB has previously provided similar specialty chemicals to other NIH...
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $24,999.10 firm fixed-price purchase order to Vizioli Omics to complete research and analysis leading to the submission of manuscripts for publication. The contract, which does not have a set-aside designation, has a period of performance through June 24, 2025. This award appears to be for a standalone project and is not associated with a larger contract vehicle.</p>
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, to Research Triangle Institute (RTI International), a non-profit research organization. The contract is for the synthesis and distribution of drugs of abuse and related compounds, with a period of performance from June 16, 2025 to June 15, 2026. The contract is a delivery order under a larger single-award Indefinite Delivery Contract (IDC) with NIDA for...
This federal contract award, with a ceiling value of $1,927,163.66, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The contract was awarded to SRI International, a non-profit research and development organization, and is part of NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract, which is a Delivery Order under the PTNP Indefinite Delivery Vehicle (IDV), is for IND-enabling studies....
This is a federal contract award to Research Triangle Institute (RTI International), a prominent non-profit research organization, by the National Institute on Drug Abuse (NIDA). The contract is for the synthesis and distribution of drugs of abuse and related compounds, as part of an Executive Order on radical transparency about wasteful spending. The contract has a period of performance from June 9, 2025 to June 8, 2026, with a ceiling value of $1,960,606.00. It is a delivery order issued under...
This is a $156,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Oncolead GMBH & CO. KG, a for-profit limited liability company located in Germany. The contract does not have a set-aside designation and was awarded on September 23, 2015 with a period of performance ending on September 30, 2016. As NIDA is the agency responsible for advancing research on drug use and addiction, this contract is likely supporting the...
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $183,731.46 firm-fixed-price purchase order contract to Oxford Stemtech LTD for scientific support services related to the generation and multiomics profiling of induced pluripotent stem cell-derived neuronal models. The contract does not have a set-aside designation, and the ultimate completion date is September 10, 2025. This contract award is not associated with a larger acquisition vehicle.</p>